VIVEbiotech Participates in the Advanced Therapies Congress 2026 in London
VIVEbiotech will be at ExCeL London for an important event in its international growth agenda.
The Advanced Therapies Congress 2026 begins tomorrow in London, bringing together global leaders and experts from across the advanced therapies sector. VIVEbiotech will be participating in this year’s edition, with members of the team traveling to ExCeL London to engage with partners, collaborators, and stakeholders.
Representing VIVEbiotech at the event will be:
- Natalia Elizalde, Chief Business Development Officer
- Andrés Lamsfus, Customer Product Development Manager
- Miguel Álvarez, Business Development Manager
In this video — available here: ENLACE — Miguel Álvarez outlines VIVEbiotech’s participation at the congress and highlights the major international events the company will attend throughout 2026 in Europe, the United States, and Asia.
Attendees interested in connecting with the VIVEbiotech team may do so through the event app or directly at our contact form or by email at [email protected].
VIVEbiotech looks forward to a productive days in London and to meeting professionals from across the sector.